Camillo L, Pozzi M, Bernardo P, Pisano S, Nobile M
Drug Des Devel Ther. 2024; 18:5023-5040.
PMID: 39525048
PMC: 11550706.
DOI: 10.2147/DDDT.S383133.
Guan J, Li F, Kang D, Anderson T, Pitcher T, Dalrymple-Alford J
Molecules. 2023; 28(3).
PMID: 36770687
PMC: 9919809.
DOI: 10.3390/molecules28031021.
Silva-Reis S, Sampaio-Dias I, Costa V, Correia X, Costa-Almeida H, Garcia-Mera X
ACS Chem Neurosci. 2023; 14(4):554-572.
PMID: 36735764
PMC: 9936549.
DOI: 10.1021/acschemneuro.2c00675.
Turkez H, Tozlu O, Tatar A, Arslan M, Cadirci K, Marinelli L
J Toxicol. 2022; 2022:3775194.
PMID: 36444193
PMC: 9701129.
DOI: 10.1155/2022/3775194.
Morales T, Stearns-Yoder K, Hoffberg A, Khan T, Wortzel H, Brenner L
Heliyon. 2022; 8(3):e09037.
PMID: 35309405
PMC: 8928062.
DOI: 10.1016/j.heliyon.2022.e09037.
Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.
Jurcau A, Simion A
Int J Mol Sci. 2022; 23(1).
PMID: 35008440
PMC: 8744548.
DOI: 10.3390/ijms23010014.
Synthesis and Characterization of Novel Methyl (3)5-(-Boc-piperidinyl)-1-pyrazole-4-carboxylates.
Matuleviciute G, Arbaciauskiene E, Kleiziene N, Kederiene V, Ragaite G, Dagiliene M
Molecules. 2021; 26(13).
PMID: 34206593
PMC: 8270337.
DOI: 10.3390/molecules26133808.
Peptides Derived from Growth Factors to Treat Alzheimer's Disease.
Gascon S, Jann J, Langlois-Blais C, Plourde M, Lavoie C, Faucheux N
Int J Mol Sci. 2021; 22(11).
PMID: 34199883
PMC: 8200100.
DOI: 10.3390/ijms22116071.
The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins in the Nervous System.
Lewitt M, Boyd G
Biochem Insights. 2019; 12:1178626419842176.
PMID: 31024217
PMC: 6472167.
DOI: 10.1177/1178626419842176.
GPE Promotes the Proliferation and Migration of Mouse Embryonic Neural Stem Cells and Their Progeny In Vitro.
Almenglo C, Devesa P, Devesa J, Arce V
Int J Mol Sci. 2017; 18(6).
PMID: 28621713
PMC: 5486102.
DOI: 10.3390/ijms18061280.
The IGF-derived tripeptide Gly-Pro-Glu is a weak NMDA receptor agonist.
Vaaga C, Tovar K, Westbrook G
J Neurophysiol. 2014; 112(6):1241-5.
PMID: 24944213
PMC: 4137256.
DOI: 10.1152/jn.00290.2014.
Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.
Sohrabji F
Front Neuroendocrinol. 2014; 36:1-14.
PMID: 24882635
PMC: 4247812.
DOI: 10.1016/j.yfrne.2014.05.003.
Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1.
Guan J, Gluckman P, Yang P, Krissansen G, Sun X, Zhou Y
Sci Rep. 2014; 4:4388.
PMID: 24633053
PMC: 3955921.
DOI: 10.1038/srep04388.
New innovations: therapeutic opportunities for intellectual disabilities.
Picker J, Walsh C
Ann Neurol. 2013; 74(3):382-90.
PMID: 24038210
PMC: 3876407.
DOI: 10.1002/ana.24002.
Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3.
Cartagena C, Phillips K, Williams G, Konopko M, Tortella F, Dave J
Neuromolecular Med. 2013; 15(3):504-14.
PMID: 23765588
DOI: 10.1007/s12017-013-8236-z.
Neurodevelopmental effects of insulin-like growth factor signaling.
OKusky J, Ye P
Front Neuroendocrinol. 2012; 33(3):230-51.
PMID: 22710100
PMC: 3677055.
DOI: 10.1016/j.yfrne.2012.06.002.
Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.
Guan J
CNS Neurosci Ther. 2010; 17(4):250-5.
PMID: 20236140
PMC: 6493898.
DOI: 10.1111/j.1755-5949.2009.00128.x.
NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats.
Wei H, Lu X, Shear D, Waghray A, Yao C, Tortella F
J Neuroinflammation. 2009; 6:19.
PMID: 19656406
PMC: 2731085.
DOI: 10.1186/1742-2094-6-19.
IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
Guan J, Gluckman P
Br J Pharmacol. 2009; 157(6):881-91.
PMID: 19438508
PMC: 2737647.
DOI: 10.1111/j.1476-5381.2009.00256.x.
Lignocaine: neuro-protective or wishful thinking?.
Mitchell S, Merry A
J Extra Corpor Technol. 2009; 41(1):P37-42.
PMID: 19361040
PMC: 4680232.